Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
ObjectivesTo evaluate the association of breast cancer with both the background parenchymal enhancement intensity and volume (BPEI and BPEV, respectively) and the amount of fibroglandular tissue (FGT) using an automatic quantitative assessment method in breast magnetic resonance imaging (MRI).Materi...
Main Authors: | Xiaoxin Hu, Luan Jiang, Chao You, Yajia Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.616716/full |
Similar Items
-
MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival
by: Roberto Lo Gullo, et al.
Published: (2020-08-01) -
Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis
by: Merav A. Ben-David, et al.
Published: (2020-02-01) -
Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
by: Daniele La Forgia, et al.
Published: (2021-04-01) -
Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
by: Na Hu, et al.
Published: (2021-02-01) -
Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
by: Michelle Zhang, et al.
Published: (2021-02-01)